Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-07-03
1993-11-09
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 8, 514 13, 514 14, 514 15, 514 16, 514 17, 514 18, 530325, 530326, 530327, 530328, 530329, 530330, 530331, 530350, 530380, 530381, 530383, 530324, A61K 3702, C07K 710
Patent
active
052602745
ABSTRACT:
Peptides which inhibit the binding of von Willebrand Factor to Factor VIII. Monoclonal antibodies capable of specifically binding to the region of von Willebrand Factor containing the Factor VIII binding domain. Improved methods of preparing Factor VIII.
REFERENCES:
patent: 5043429 (1991-08-01), Zimmerman et al.
Titani, K. et al., Biochemistry, 25: 3174-3184, 1986.
Sadler, J. et al., Proc. Natl. Acad. Sci., USA 82: 6394-6398, Oct. 1985.
Alberts et al., Molecular Biology of the Cell, Garland Publishing Inc., pp. 185-196, 1983.
Stewart et al., Solid Phase Peptide Synthesis, 2nd ed., Pierce Chemical Co., 1984.
Foster Paul A.
Fulcher Carol A.
Zimmerman Theodore S.
Lee Lester L.
Scripps Clinic and Research Foundation
LandOfFree
Factor VIII binding domain of von Willebrand Factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor VIII binding domain of von Willebrand Factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor VIII binding domain of von Willebrand Factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142769